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Summary. Background: Atherothrombosis underlies acute
coronary syndromes, including unstable angina and acute
myocardial infarction. Within the unstable plaque, mono-
cytes express collagenolytic matrix metalloproteinases
(MMPs), including MMP-13, which degrades fibrous col-
lagen. Following rupture, vessel wall components includ-
ing degraded collagen are exposed to circulating platelets.
Platelet receptors then mediate the recruitment and acti-
vation of platelets to form a thrombus, blocking blood
flow and resulting in myocardial infarction and sudden
death. Objectives: Here we aim to provide information
on the effects of collagen degradation on platelet adhe-
sion and thrombus formation. Methods: Using increasing
concentrations of MMP-13, we induced progressive
degradation of fibrous and monomeric collagen I, visual-
ized by electrophoresis, and then investigated the capacity
of the resulting fragments to support static platelet adhe-
sion and thrombus formation in whole flowing blood.
Results: Both integrin and glycoprotein VI-dependent
interactions with fibrous collagen underpin high levels of
platelet adhesion under both conditions, with little obvi-
ous effect of MMP-13 treatment. Static platelet adhesion
to monomeric collagen was strongly a2b1-dependent
regardless of degradation status. Under flow conditions,
partially degraded monomeric collagen supported
increased thrombus deposition at 10 lg mL1 MMP-13,
falling close to background when collagen degradation
was complete (100 lg mL1 MMP-13). Conclusions: New
binding activities come into play after partial digestion of
collagen monomers, and net platelet-reactivity through
all axes is abolished as degradation becomes more
complete.
Keywords: collagen; collagenase; platelets; GPVI collagen
receptor; matrix metalloproteinase 13.
Following atherosclerotic plaque rupture, circulating pla-
telets bind to exposed vessel wall collagens, where they
initiate arterial thrombosis [1]. Specific receptors mediate
platelet recognition of and adhesion to collagen. GPIba
binds to immobilized von Willebrand factor (VWF) in
the vessel wall, initiating platelet capture [2], and glyco-
protein (GP)VI binds directly to collagen and activates
platelets. Integrin a2b1 stabilizes the early stages of the
platelet-collagen interaction, and integrin aIIbb3 sup-
ports platelet-platelet interactions mediated by fibrinogen
and VWF.
During plaque development, smooth muscle cells
deposit excess collagens I and III within the subendothe-
lial intimal space [3]. Collagen is resistant to most prote-
olytic degradation, and whilst healthy arteries do not
express active collagenases, in the unstable plaque macro-
phages secrete matrix metalloproteinase (MMP)-1 and
MMP-13, which cleave collagen[4–6], leaving behind
bioactive fragments that may target cells downstream
from the site of injury [3]. Despite this, little is known
about the effects of progressive collagen proteolysis on
platelet recognition. Here we investigate the relationship
between MMP-13 treatment and platelet adhesion to
fibrous and monomeric collagen I under static and shear
conditions.
Methods
Proteolytic digestion of collagen I by MMP-13
ProMMP-13 was activated using 1 mM 4-aminophenyl-
mercuric acetate for 1 h at 37 °C, and dialysed at 4 °C
against 50 mM TBS. Active MMP-13 (0–100 lg mL1)
was added to either monomeric (Devro, Chryston, Scot-
land) or fibrous (Ethicon Corp., Somerville, NJ, USA)
bovine collagen I (1 mg mL1) and incubated for 16 h at
37 °C.
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SDS-PAGE of collagen samples
Digested collagens were separated by reducing elec-
trophoresis on 4–12% NuPage bis-tris gels (Invitrogen,
Paisley, UK) and Coomassie stained.
Human washed platelet preparation
Venous platelets were isolated from healthy volunteers as
previously described [7] and counted using a Z2 counter
(Beckman Coulter, High Wycombe, UK).
Adhesion assays
Platelet adhesion assays were conducted as previously
described [7]. The anti-aIIbb3 compound GR144053
(4-[4-[4-(aminoiminomethyl]-1-piperazinyl]-1-piperidineacetic
acid hydrochloride trihydrate) was purchased from Cal-
biochem, Watford, UK. The a2b1-binding peptide, GFO-
GER (GCP(GPP)5-GFOGER-(GPP)5-GCP) courtesy of
Dr Dominique Bihan) and anti-GPVI scFv were gener-
ated as previously described [8,9]. The anti-a2b1 mono-
clonal antibody was a gift from Dr Barry Coller,
Rockefeller University, New York. Ninety-six-well Immu-
lon 2HB plates (Nunc, Thermo Scientific, Paisley, UK)
were coated with 1 lg digested collagen/MMP-13 solution
or the controls (GFOGER or bovine serum albumin
(BSA)) in 100 lL 0.01 M acetic acid, and left overnight at
4 °C. Washed platelets (100 lL at 1.5 9 108 mL1) in
calcium free tyrodes (CFT) containing 2 mM Mg2+ or
EDTA were allowed to adhere for 1 h following pre-incu-
bation for 20 min at room temperature with GR144053
(10 lM) or anti-GPVI/a2b1 (10 lg mL1) as indicated.
The wells were washed, lysed and platelet binding quanti-
fied using a colorimetric alkaline phosphatase assay [7].
Whole blood perfusion experiments
Blood was collected into 40 lM D-Phenylalanyl-L-pro-
lyl-L-arginine chloromethyl ketone (PPACK, Enzo Life
Sciences, Exeter, UK), supplemented hourly with 10 lM
PPACK, and mixed with 1 lM 3,3’dihexyloxacarbocya-
nine iodide dye (DIOC6) 15 min before use. Glass cov-
erslips were coated with (10 lg) collagen solution in
0.01 M acetic acid and left overnight at 4 °C. Slides
were blocked with bovine serum albumin (BSA) (1% w/
v) for 30 min and blood then drawn through the cham-
ber at a wall shear rate of 1000 s1, mimicking arterio-
lar conditions. Images (field size 360 9 360 lm) were
taken from three separate areas of the slide; 0.69-lm
Z–stacks encompassing the entire thrombus height were
collected using an Olympus FV 300 confocal micro-
scope and an UplanFLN 40x NA1.30 oil immersion
objective and processed using ImageJ1.35 software
(NIH, Bethesda, MD, USA) to determine thrombus vol-
ume [10].
Results and discussion
Visualization of collagen degradation by SDS-PAGE
Proteolysis of monomeric collagen I is proportional to
enzyme concentration, with the a1 and a2 chains disap-
pearing at 40 lg mL1 and any background smearing
above 150 kDa clearing with progressive proteolysis.
MMP-13 acts at the collagenase cleavage site, located at
Gly906-Leu907, ¾ of the way along the collagen a chain
[11]. The ¾ fragments are visible at ~75 and 90 kDa, and
the ¼ fragment at 25 kDa alongside an increasing level of
autolysed MMP-13 [12] (Fig. 1A). For monomeric colla-
gen, proteolysis at 37 °C yields an additional, stable band
below the ¾ fragments not seen at 24 °C (data not
shown). As expected, some of the large cross-linked
fibrous collagen is unable to enter the gel, and so degra-
dation is observed first as increased density at 250–100
kDa in the 10–30 lg mL1 lanes, then as a decrease in
aggregate material above 150 kDa (Fig. 1B). Following
incubation at 37 °C for 16 h, the MMP-13 control has
undergone virtually complete autolysis into small frag-
ments [13].
The structure of a collagenase is highly conserved, com-
prising pro-peptide, catalytic (Cat) and hemopexin (Hpx)-
like domains [14]. Cat and Hpx cooperate to recognize
and bind collagen adjacent to its cleavage site [15] with
Hpx-mediated helix relaxation enabling hydrolysis. Subse-
quent gelatinolytic degradation of the clipped a chains by
MMP-13 [16,17] has the potential to influence recognition
of collagen by platelet adhesion receptors, and these data
are presented below.
Static platelet adhesion to MMP-degraded collagens
Mg2+-dependent, integrin-mediated static platelet adhe-
sion to monomeric collagen I [7,8] remained unchanged
regardless of the extent of collagen degradation (Fig. 2A).
Pre-incubation with EDTA or an anti-a2b1 antibody
(subsequent, separate experiments) abolished all adhesion,
confirming that the interaction absolutely requires inte-
grin a2b1, with only modest contribution from GPVI
(Fig. 2B). Messent et al. [12] found that the linear ¼ frag-
ment did not bind a2b1. Together, these data suggest that
platelet adhesion to MMP-13-digested monomeric colla-
gen is primarily mediated through the ¾ fragment (where
GFOGER and other high-affinity a2b1-binding sites
reside [18]; see Fig. 3). In this scenario, the MMP-
13-mediated loss of the weak a2b1-binding sites and the
C-terminal Gly-pro-Hyp-rich tract, a putative GPVI
recognition motif present in the ¼ fragment, make little
discernible contribution to static platelet binding. Autol-
ysed MMP-13 did not support platelet adhesion.
Static platelet adhesion to fibrous collagen I displayed
a constant Mg2+-dependent element regardless of MMP-
13 treatment (Fig. 2C), which was reduced but not abol-
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ished by EDTA, suggesting both integrin-dependent and
integrin-independent contributions. The anti-GPVI scFv
in the presence of EDTA reduced platelet adhesion by
~70% relative to control and by ~40% relative to EDTA
alone (each P < 0.001, one-way ANOVA and Dunnett’s
test), showing that GPVI contributes to integrin-indepen-
dent binding. Although a2b1 and/or aIIbb3 inhibition
also reduced integrin-dependent adhesion (P < 0.001),
neither blockade affected metal ion-independent binding
(Fig. 2D).
In order to bind to collagen fibers, GPVI dimerises on
the platelet surface [19]. Our results suggest that whilst
fibrous collagen provides ample accessible sites, the plate-
let GPVI dimer has little affinity for collagen monomers
or proteolytic fragments and so is unlikely to support
platelet adhesion to digested collagen. Some adhesion to
fibers remains following combined a2b1, GPVI and
aIIbb3 blockade, suggesting contributions by other mech-
anisms. Further studies may identify the receptors
responsible.
Flow-dependent thrombus formation of whole blood is
differentially regulated on digested monomeric collagen
Shear stress is critical for VWF-dependent platelet recruit-
ment to collagen. In flowing blood, platelet attachment to
collagen is initiated by GPIba binding to the A1 domain
of immobilized VWF, the first step in thrombus forma-
tion [20,21]. Using specific collagen-derived peptides, we
observed that VWF is required for thrombus deposition
at high shear rates, together with either high-affinity a2b1
or GPVI, or preferably both [10].
The first experiments using digested monomeric colla-
gen showed a linear decline, P < 0.0001, in surface cover-
age with MMP-13 level, from the control value of
33 000 lm2 to 8000 lm2 after treatment with MMP-13 at
100 lg mL1 (Fig. 4A, left panel). One point
(10 lg mL1) was markedly above the 95% confidence
range, at a value of 42 000 lm2. A corresponding fall in
thrombus volume, P < 0.0001, (Fig. 4B, left panel) was
observed, again with an outlying value at an MMP-13
level of 10 lg mL1. This modest rise in platelet adhesion
suggests increased accessibility of cryptic motifs (such as
Arg-Gly-Asp (RGD); inactive in triple-helical collagens,
but active in linear peptides), which may engage integrins
other than a2b1 such as aIIbb3. To examine this effect of
MMP-13 at 10 lg mL1 more closely, seven further
experiments were conducted with or without pre-incuba-
tion of whole blood with the aIIbb3 antagonist,
GR144053. These experiments showed significantly
greater surface coverage (P < 0.05, repeated measures
ANOVA) after MMP-13 treatment, from 53 500 to
60 000 lm2, confirming the anomalous point in Fig. 4(A,
B). GR144053 reduced mean surface coverage from
47 500 and 55 500 lm2 on control and MMP-13-treated
collagen monomers (10 lg mL1) to 46 000 and
41 000 lm2, respectively (P < 0.01 and 0.001, respectively,
Fig. 4C). The antagonist reduced the thrombi to a lawn
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Fig. 1. Visualization of (A) monomeric and (B) fibrous collagen I degradation by SDS-PAGE under reducing conditions. Activated matrix met-
alloproteinase (MMP)-13 (total volume of 10 lL) was added to the collagens and degradation allowed to proceed for 16 h at 37 °C. Gels are
representative of nine repeated experiments (n = 9). Intact collagen I a1 and a2 chains and their ¾ fragments are marked for reference.
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Fig. 2. (A). Adhesion of washed platelets to ELISA wells coated with matrix metalloproteinase (MMP)-13-digested monomeric collagen, the
a2b1 recognition peptide GFOGER and a negative control (bovine serum albumin, BSA). (B) Platelet adhesion to monomeric collagen I in the
presence of anti-a2b1 and anti-GPVI antibodies or anti-aIIbb3 compound where stated. (C) Adhesion of washed platelets to ELISA wells
coated with MMP-13 digested fibrous collagen solution and the a2b1 collagen recognition peptide GFOGER. (D) Platelet adhesion to fibrous
collagen I in the presence of anti-a2b1, anti-GPVI antibodies or anti-aIIbb3 compound where stated. Platelets were allowed to adhere for 1 h
at room temperature prior to washing, lysis and assay as described in the Methods section. Experiments were performed in the presence of
2 mM Mg2+ (grey bars) or 2 mM EDTA (black bars). Data represent the mean  SE of at least three experiments. In B and D, *P < 0.05,
§P < 0.01, †P < 0.001 (one-way ANOVA and Dunnett’s multiple comparison test) relative to untreated platelets in either the presence of Mg2+ or
EDTA, as appropriate.
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Fig. 3. Schematic representation of key sites in the collagen I a1 and a2 chains. The matrix metalloproteinase (MMP)-13 cleavage site, von
Willebrand factor (VWF) binding site and GPVI binding sites are denoted. Also represented are: *low-, **intermediate- and ***high-affinity
GxxGER a2b1 integrin recognition sites.
© 2015 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Throm-
bosis and Haemostasis.
2256 J. -M. Howes et al
of single platelets (Fig. 4D). Importantly, the elevated
surface coverage after MMP-13 treatment was abolished
by aIIbb3 blockade. These data are consistent with an
increase in either the aIIbb3-reactivity of collagen mono-
mers after limited digestion or their ability to activate
aIIbb3; the former explanation appears more likely; we
know of no activatory receptor that is regulated by non-
helical collagens. It is worth noting that inter-donor dif-
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Fig. 4. Deposition of platelets on matrix metalloproteinase (MMP)-13 digested monomeric or fibrous collagen I in whole blood under flow
conditions. Surfaces were prepared and blood was drawn through the perfusion chamber for 5 min as described in the Methods section.
Results shown are mean values  SEM plotted vs. [MMP-13] used to digest the collagen. 95% confidence intervals are also shown for the best
fit lines, calculated by linear regression (Prism 5 for Mac OSX). (A) Surface coverage of platelets on monomeric collagen (left) or fibrous colla-
gen (right), n ≥ 4, combining all data from nine experiments. (B) Thrombus volume measured in the same experiments. (C) The mean surface
coverage from additional experiments using monomeric collagen with or without treatment with 10 lg/mL1 MMP-13, performed in the pres-
ence or absence of the aIIbb3 antagonist, GR144053 (n = 7); *P < 0.05, §P < 0.01, †P < 0.001. (D) Representative images of platelet aggregates
from (C).
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ferences accounted for over half the variance observed
here.
On MMP-13-treated fibrous collagen, platelet surface
coverage and volume followed a similar pattern, falling in
a linear fashion towards zero (P = 0.0003 and 0.0002,
respectively) (Figs 4A,B, right panels). The data for both
forms of collagen contrast with the static adhesion results,
which showed no significant change in platelet adhesion
regardless of the degree of collagen proteolysis. The
thrombus volume reflects the aggregation of activated
platelets, and is most likely higher for fibrous collagen
than monomeric collagen as a result of the engagement of
GPVI dimers by the former but not the latter. As the
proteolysis of each collagen form continues, it is likely
that these binding sites are all progressively destroyed,
inevitably resulting in near-total loss of platelet adhesion.
Although collagenolytic MMPs can cleave the collagen
molecule at several loci [22], substrate specificity and thus
proteolysis are strictly governed by the tightly regulated
structure of the collagen fibril, resulting in preferential
cleavage at the canonical ¾–¼ site. In the intact fibril,
access to this site may be restricted by a C-telopeptide,
which must be removed to permit collagenolysis [23]. How-
ever, the Cat domain of MMP-13 can cleave the non-
helical N-telopeptide of collagen I [24], and similar activity
has been proposed at the C-terminus. As degradation of
the fibril proceeds, therefore, removal of the outer fibril
components may reveal previously hidden cleavage as well
as cell adhesion sites [23,25]. For fibrous collagen, our sta-
tic adhesion experiments report that the sites available for
platelet adhesion are both integrin- and GPVI-dependent,
which are abolished by the chelation of Mg2+ and the pres-
ence of an anti-GPVI scFv, respectively (Fig. 2D).
In conclusion, proteolytic degradation of an intact col-
lagen fibril within an atherosclerotic plaque is likely to be
a complex and iterative process, determined by the acces-
sibility of its collagenase cleavage sites. Platelet reactivity
will vary as proteolysis proceeds, as buried or cryptic
receptor binding sites within the fibril are revealed and as
monomers or smaller fragments released. Ultimately, it
seems likely that collagenase activity will reduce the fibril
to small components that are unreactive under shear con-
ditions and become dispersed.
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